Kindly note the image has been posted only for representational purposes.Photograph: Kind courtesy Pixabay.com The Indian pharmaceutical industry's recent tryst with the US drug regulator......
'Even if Serum Institute and Bharat Biotech were successful in ramping up production overnight, what happens to the capacity after the demand from India is met?' asks Sanjeev Nayyar. IMAGE: A......
Initial data has shown immunity triggered by the two mRNA vaccines -- Pfizer-BioNTech and Moderna -- lasts for at least six months, reports Sohini Das. IMAGE: Dr Mayank Amin draws the......
Prime Minister Narendra Modi on Friday held a meeting to review India's COVID-19 vaccination strategy in which issues like prioritisation of population groups, including health and other frontline......
The Oxford University COVID-19 vaccine undergoing Phase III clinical trials with British pharma giant AstraZeneca is doing 'everything expected' which means good news in the fight against the......
The sharp pullback in mid and smallcap stocks signals a cooling-off period in segments that previously attracted considerable investor interest. Illustration: Dominic Xavier/Rediff.com Over......
A sharp fall in the equity market made investors poorer by Rs 5.29 lakh crore on Tuesday when the BSE benchmark Sensex tumbled over 800 points. Photograph: Danish Siddiqui/Reuters A host of......
With Donald Trump all set to become US president, Indian exporters may face high customs duties for goods like automobiles, textiles and pharmaceuticals if the new US administration decides to......
Research and development (R&D) spending by BSE 100 companies has grown steadily, rising from 0.89 per cent of revenue in FY20 to 1.32 per cent in FY24, averaging around 1 per cent over the period......
Benchmark equity indices Sensex and Nifty ended lower on Wednesday, after hitting fresh record high levels during the morning trade, dragged by IT stocks as investors preferred to book profits......